- New Purchases: NVO, ALXN, SNY, CELG, LH, ABBV, NVRO, EW, CHRS, BLUE, XRAY, VAR, FMS, BPMC, PRGO, PBYI, AKRX, SGEN,
- Added Positions: GWPH, BAX, MOH, HCA, ELAN, MYL, HUM, BIO, INCY, DHR, LLY, ANTM, TMO, SNN, BHC, REGN, CNC, AGIO, WCG, UHS, AZN, DXCM, TEVA, WMGI, BSX,
- Reduced Positions: ISRG, BIIB, ABT, QGEN, BMRN, VRTX, SYK, ILMN, SRPT, LHCG, A,
- Sold Out: CI, UNH, XBI, ZBH, MCK, LOXO, ABC, HAE,
For the details of Sivik Global Healthcare LLC's stock buys and sells, go to https://www.gurufocus.com/guru/sivik+global+healthcare+llc/current-portfolio/portfolio
These are the top 5 holdings of Sivik Global Healthcare LLC- WellCare Health Plans Inc (WCG) - 35,000 shares, 3.48% of the total portfolio. Shares added by 7.69%
- Eli Lilly and Co (LLY) - 70,000 shares, 3.35% of the total portfolio. Shares added by 27.27%
- Boston Scientific Corp (BSX) - 225,000 shares, 3.19% of the total portfolio. Shares added by 2.27%
- Baxter International Inc (BAX) - 105,000 shares, 3.15% of the total portfolio. Shares added by 75.00%
- Abbott Laboratories (ABT) - 100,000 shares, 2.95% of the total portfolio. Shares reduced by 13.04%
Sivik Global Healthcare LLC initiated holding in Novo Nordisk A/S. The purchase prices were between $46.07 and $52.63, with an estimated average price of $49.1. The stock is now traded at around $48.56. The impact to a portfolio due to this purchase was 2.61%. The holding were 135,000 shares as of .
New Purchase: Alexion Pharmaceuticals Inc (ALXN)Sivik Global Healthcare LLC initiated holding in Alexion Pharmaceuticals Inc. The purchase prices were between $97.36 and $137.75, with an estimated average price of $123.89. The stock is now traded at around $133.71. The impact to a portfolio due to this purchase was 2.24%. The holding were 45,000 shares as of .
New Purchase: Sanofi SA (SNY)Sivik Global Healthcare LLC initiated holding in Sanofi SA. The purchase prices were between $40.83 and $45.43, with an estimated average price of $42.82. The stock is now traded at around $41.14. The impact to a portfolio due to this purchase was 2.12%. The holding were 130,000 shares as of .
New Purchase: Celgene Corp (CELG)Sivik Global Healthcare LLC initiated holding in Celgene Corp. The purchase prices were between $64.09 and $94.34, with an estimated average price of $87.12. The stock is now traded at around $95.77. The impact to a portfolio due to this purchase was 2.09%. The holding were 60,000 shares as of .
New Purchase: Laboratory Corp of America Holdings (LH)Sivik Global Healthcare LLC initiated holding in Laboratory Corp of America Holdings. The purchase prices were between $123.7 and $156.3, with an estimated average price of $143.14. The stock is now traded at around $163.51. The impact to a portfolio due to this purchase was 1.41%. The holding were 25,000 shares as of .
New Purchase: AbbVie Inc (ABBV)Sivik Global Healthcare LLC initiated holding in AbbVie Inc. The purchase prices were between $77.14 and $92.19, with an estimated average price of $82.08. The stock is now traded at around $78.40. The impact to a portfolio due to this purchase was 1.26%. The holding were 42,500 shares as of .
Added: GW Pharmaceuticals PLC (GWPH)Sivik Global Healthcare LLC added to a holding in GW Pharmaceuticals PLC by 500.00%. The purchase prices were between $97.39 and $177.34, with an estimated average price of $147.85. The stock is now traded at around $185.49. The impact to a portfolio due to this purchase was 1.56%. The holding were 30,000 shares as of .
Added: Baxter International Inc (BAX)Sivik Global Healthcare LLC added to a holding in Baxter International Inc by 75.00%. The purchase prices were between $64.48 and $81.31, with an estimated average price of $72.66. The stock is now traded at around $77.06. The impact to a portfolio due to this purchase was 1.35%. The holding were 105,000 shares as of .
Added: Molina Healthcare Inc (MOH)Sivik Global Healthcare LLC added to a holding in Molina Healthcare Inc by 83.33%. The purchase prices were between $105.9 and $148.29, with an estimated average price of $134.96. The stock is now traded at around $129.46. The impact to a portfolio due to this purchase was 1.31%. The holding were 55,000 shares as of .
Added: HCA Healthcare Inc (HCA)Sivik Global Healthcare LLC added to a holding in HCA Healthcare Inc by 71.43%. The purchase prices were between $119.44 and $144.26, with an estimated average price of $134.31. The stock is now traded at around $125.09. The impact to a portfolio due to this purchase was 1.2%. The holding were 60,000 shares as of .
Added: Elanco Animal Health Inc (ELAN)Sivik Global Healthcare LLC added to a holding in Elanco Animal Health Inc by 109.24%. The purchase prices were between $29 and $32.83, with an estimated average price of $30.78. The stock is now traded at around $31.39. The impact to a portfolio due to this purchase was 1.08%. The holding were 175,000 shares as of .
Added: Mylan NV (MYL)Sivik Global Healthcare LLC added to a holding in Mylan NV by 166.97%. The purchase prices were between $26.01 and $32.1, with an estimated average price of $29.18. The stock is now traded at around $21.99. The impact to a portfolio due to this purchase was 0.98%. The holding were 150,000 shares as of .
Sold Out: Cigna Corp (CI)Sivik Global Healthcare LLC sold out a holding in Cigna Corp. The sale prices were between $159.69 and $199.81, with an estimated average price of $183.17.
Sold Out: UnitedHealth Group Inc (UNH)Sivik Global Healthcare LLC sold out a holding in UnitedHealth Group Inc. The sale prices were between $236.02 and $271.13, with an estimated average price of $255.35.
Sold Out: SPDR Series Trust S&P Biotech (XBI)Sivik Global Healthcare LLC sold out a holding in SPDR Series Trust S&P Biotech. The sale prices were between $71.21 and $91.92, with an estimated average price of $84.86.
Sold Out: Zimmer Biomet Holdings Inc (ZBH)Sivik Global Healthcare LLC sold out a holding in Zimmer Biomet Holdings Inc. The sale prices were between $100.43 and $129.56, with an estimated average price of $116.76.
Sold Out: McKesson Corp (MCK)Sivik Global Healthcare LLC sold out a holding in McKesson Corp. The sale prices were between $110.47 and $136.3, with an estimated average price of $123.47.
Sold Out: Loxo Oncology Inc (LOXO)Sivik Global Healthcare LLC sold out a holding in Loxo Oncology Inc. The sale prices were between $131.02 and $234.75, with an estimated average price of $222.49.
Here is the complete portfolio of Sivik Global Healthcare LLC. Also check out:
1. Sivik Global Healthcare LLC's Undervalued Stocks
2. Sivik Global Healthcare LLC's Top Growth Companies, and
3. Sivik Global Healthcare LLC's High Yield stocks
4. Stocks that Sivik Global Healthcare LLC keeps buying